Fluence is a company that offers continuing education and certificate programs in psychedelic integration and psychedelic-assisted therapy. They provide training and education with both independently and in collaboration with various clinics, conferences, private practices, non-profit associations, retreat centres, and psychedelic research sponsors.
Their programs are designed for licensed professionals and advanced graduate students who work with patient populations. Many of their classes and programs are open to anyone who wishes to attend. The company’s mission is to increase awareness, availability, and safety of psychedelic therapies and related healthcare. The leadership team at Fluence includes co-founders Dr. Elizabeth Nielson and Dr. Ingmar Gorman, both of whom are experienced psychologists focused on developing psychedelic medicines as empirically supported treatments for PTSD, substance use problems, and mood disorders. Both have served as therapists on FDA-approved clinical trials, and have published on topics related to psychedelic therapy.
Fluence
Fluence announced on the 16th of February 2022 that it had completed a $3 million seed funding round. This completes Fluence’s initial fundraising round, the first close of which was announced on November 4, 2021.
Fluence originated from Liberty Psychological Services (PLLC), a private psychological services company owned and operated by Dr. Ingmar Gorman and Dr. Elizabeth Nielson.
Activities
B2C
Educational / Training
Explore more company info with a Tree membership
📰 Weekly newsletter about the business of psychedelics
📈 Extended company information (analyst view, fundraising, revenue numbers)
🪄 Priority company page updates
Related Course(s)
Certificate in Psychedelic Therapy and IntegrationThe Certificate in Psychedelic Therapy and Integration equips clinicians with essential skills and knowledge for effective psychedelic-assisted therapy.
Advanced Certificate MDMA-Assisted Therapy
The Education Program in MDMA-Assisted Therapy by Fluence offers clinicians a comprehensive understanding of MDMA-assisted therapy, focusing on trauma-informed care.
Internal Family Systems and Psychedelics Clinical Consultation Group
The Internal Family Systems (IFS) and Psychedelics Clinical Consultation Group by Fluence offers a six-week program for IFS-informed clinicians.
Introduction to Ketamine-Assisted Therapy
The Introduction to Ketamine course equips clinicians with foundational knowledge and practical skills for effective ketamine-assisted psychotherapy.
Applied Mindfulness for Psychedelic Therapists
Applied Mindfulness for Psychedelic Therapists offers therapists a comprehensive exploration of integrating mindfulness into psychedelic therapy and Psychedelic Harm Reduction and Integration (PHRI) sessions.
Introduction to Psilocybin-Assisted Therapy
This Introduction to Psilocybin-Assisted Therapy provides an in-depth exploration of clinical research, pharmacology, therapeutic models, and ethical considerations in psilocybin therapy.
Ayahuasca The Basics for Therapists
This on-demand course introduces clinicians to the foundational elements of ayahuasca, covering its cultural significance, therapeutic uses, pharmacology, and transformative effects.
Psychotherapeutic Touch Workshop
The Psychotherapeutic Touch Workshop is a four-hour introductory course for Integrative Psychedelic Professionals. The course explores the impact of touch culture and history on clients and offers comprehensive training on the ethics and skills of psychotherapeutic touch.
Foundations of Psychedelic Therapy
The Foundations of Psychedelic Therapy course is a 12-week reading and study group designed to provide a comprehensive overview of the concepts, models, and ideas central to psychedelic therapy.
Poetry, Symbols, and Story in Psychedelic Therapy
The Poetry, Symbols, and Story in Psychedelic Therapy course is a 12-week, interactive and experiential course that focuses on using poetry therapy as a tool in psychedelic therapy. Participants will delve into the theoretical foundations and practice techniques of Poetry Therapy and learn to use language, symbol, and story to help clients in individual, group, and community settings.
Trauma-Informed Psychedelic-Assisted Therapy
This 4-day in-person workshop is designed for therapists who want to learn about trauma-informed psychedelic-assisted therapy. It covers essential topics such as the impact of drug policy and systemic inequality on the provision and practice of psychedelic-assisted therapy, the role of intergenerational trauma and trauma of oppression, and the practitioner’s role in a trauma-informed care model.
Psychedelics and Psychoanalysis
This 12-week Psychoanalytic Psychedelic Clinical Consultation Group is designed for analytically oriented therapists and other practitioners to discuss their clinical work in psychedelic integration within the discourse of psychoanalysis.
Buddhism and Psychedelic Therapy
The course Buddhism & Psychedelic Therapy offers a unique blend of traditional Buddhist wisdom and the cutting-edge field of psychedelic-assisted therapy. This course bridges the gap between the two, providing a comprehensive overview of the intersection of these practices.
Introduction to Ketamine for Mental Health
The Introduction to Ketamine for Mental Health course provides a quick exploration of the latest research and clinical applications of ketamine in mental health treatment.
Navigating the Regulatory Process for Psychedelic Medicine
Navigating the Regulatory Process for Psychedelic Medicine is an introductory course designed for clinicians interested in learning about the history, current state, and future prospects of psychedelic medicines and therapies.
Navigating Scope of Practice for Ketamine-Assisted Psychotherapy (KAP)
Navigating Scope of Practice for Ketamine-Assisted Psychotherapy (KAP) is designed for mental health professionals interested in learning about the latest developments in ketamine-assisted psychotherapy and its scope of practice.
Advanced Certificate In Psychedelic Integration
The Certificate in Psychedelic Harm Reduction and Integration equips clinicians with practical skills to support clients before and after psychedelic experiences
Analytic Explorations in Psychedelic Therapy
Analytic Explorations in Psychedelic Therapy is a 12-week course that focuses on applying psychoanalytic concepts and theory to contemporary psychedelic therapy.
Mindfulness Based Stress Reduction for Psychedelic Therapists
The Mindfulness Based Stress Reduction for Psychedelic Therapists course offers a comprehensive curriculum for developing mindfulness practices in support of personal and professional growth for Psychedelic Therapists.
Psychedelic Integration: Premise & Promise
Psychedelic Integration: Premise & Promise is a foundational course offered by Fluence, designed for clinicians and healthcare providers interested in learning about Psychedelic Harm Reduction and Integration in clinical practice.
Intoxication and Dissociation in Psychedelic-Assisted Therapy
Intoxication & Dissociation in Psychedelic-Assisted Therapy is a two-hour introductory course aimed at exploring the potential benefits and drawbacks of the utilization of psychedelic substances in therapy.
American Trip Webinar
The American Trip webinar is available for free, but not currently on offer by Fluence so will only be visible here for historic purposes.
Advanced Certificate in Ketamine-Assisted Psychotherapy
The Certificate in Ketamine-Assisted Psychotherapy trains clinicians in ethical, practical, and business aspects of ketamine therapy for effective client support.
Understanding Ketamine
The Understanding Ketamine online workshop is a two-day training program designed for therapists, psychologists, physicians, and other healthcare professionals who want to learn about the basics of ketamine and its application in treating depression and mood disorders.
Integrating Psychedelics with Evidence-Based Therapy
Integrating Psychedelics with Evidence-Based Therapy is a 12-week reading and study group for individuals interested in evidence-based therapy and its application in psychedelic therapy. The course is designed for clinicians, graduate students, researchers, or the public who have a background in the scientific understanding of clinical interventions.
Integration Essentials
The Integration Essentials course is a 12-week program designed for therapists and healthcare providers who want to gain a deeper understanding of key concepts in psychedelic integration work. This course will provide a comprehensive study of various perspectives on psychedelic healing, including academic research, mindfulness-based psychotherapy, and indigenous wisdom traditions.
Psychedelic Psychopharmacology
The course Psychedelic Psychopharmacology is designed for healthcare professionals, graduate students, researchers, or the general public with an interest in the biological responses that influence the efficacy and safety of psychedelic therapy.
Access and Inclusion in Psychedelic Treatment
The Access and Inclusion in Psychedelic Treatment Webinar Series is an on-demand 10-session educational experience that focuses on exploring the current challenges and future opportunities for promoting social justice within the field of psychedelic medicine.
Certificate in Psilocybin-assisted Therapy
The Certificate in Psilocybin-Assisted Therapy is a program designed for therapists seeking to obtain the training and education necessary to become a licensed Psilocybin Facilitator under Oregon’s Measure 109.
KAP Theory and Methodology
The KAP Theory & Methodology course is a comprehensive, 12-week hybrid program that teaches a theoretically grounded methodology for Ketamine-assisted Psychotherapy (KAP). The course is the core component of the Postgraduate Certificate in Ketamine-assisted Psychotherapy.
Company News
Group Ketamine Pilot; Therapist Training Platform's Seed Round; Durable Response to PAT at 12 Month Follow up (The Trip Report, 18 February 2022)The Trip Report goes through the latest psychedelic news from February 2022. Highlights include Novamind's ketamine-assisted therapy, Fluence's $3 million seed round, and reporting on the 12-month Johns Hopkins depression follow-up study.